Normal Stress-only Versus Standard Stress/rest Myocardial Perfusion Imaging: Similar Patient Mortality with Reduced Radiation Exposure
Overview
Affiliations
Objectives: The aim of this study was to determine whether a normal stress-only single-photon emission computed tomographic myocardial perfusion tomography (SPECT) study confers the same prognosis as a normal SPECT on the basis of evaluation of stress and rest images.
Background: Current guidelines recommend stress and rest imaging to confirm that a SPECT study is normal.
Methods: We determined all-cause mortality in 16,854 consecutive patients who had a normal gated stress SPECT. Median follow-up was 4.5 years. A stress-only protocol was used in 8,034 patients (47.6%), whereas 8,820 (52.4%) had both stress and rest imaging.
Results: The overall unadjusted annual mortality rate in patients who had a normal SPECT with a stress-only protocol was lower than in those who required additional rest imaging (2.57% vs. 2.92%, p = 0.02). After adjustment for baseline clinical characteristics no significant differences in patient mortality were seen between the 2 imaging protocols, but the stress-only group received a 61% lower radiopharmaceutical dosage. Independent predictors of worse survival included increasing age, male sex, diabetes, history of coronary artery disease, and inability to exercise (all p < 0.001) but not the type of SPECT protocol used to image patients.
Conclusions: Patients determined to have a normal SPECT on the basis of stress imaging alone have a similar mortality rate as those who have a normal SPECT on the basis of evaluation of both stress and rest images. Our results support that additional rest imaging is not required in patients who have a normally appearing initial stress study. A significant reduction in radiation exposure can be achieved with such an approach.
Huck D, Divakaran S, Weber B, Brown J, Lopez D, Souza A J Nucl Cardiol. 2024; 40:101908.
PMID: 38996910 PMC: 11527573. DOI: 10.1016/j.nuclcard.2024.101908.
Martineau P, Pelletier-Galarneau M, Slomka P, Goertzen A, Leslie W Nucl Med Commun. 2023; 44(12):1087-1093.
PMID: 37706261 PMC: 466936. DOI: 10.1097/MNM.0000000000001768.
Kamerman M, van Dijk J, Timmer J, Ottervanger J, Knollema S, Jager P J Nucl Cardiol. 2023; 30(6):2692-2701.
PMID: 37592058 DOI: 10.1007/s12350-023-03349-6.
Cardiac Imaging in Women with Ischemic Heart Disease.
Peix A Life (Basel). 2023; 13(6).
PMID: 37374171 PMC: 10304139. DOI: 10.3390/life13061389.
Hage F, Einstein A, Ananthasubramaniam K, Bourque J, Case J, DePuey E J Nucl Cardiol. 2023; 30(2):864-907.
PMID: 36607538 DOI: 10.1007/s12350-022-03162-7.